These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 25060294

  • 1. Is diffusion-weighted MRI superior to FDG-PET or FDG-PET/CT in evaluating and predicting pathological response to preoperative neoadjuvant therapy in patients with rectal cancer?
    Li YL, Wu LM, Chen XX, Delproposto Z, Hu JN, Xu JR.
    J Dig Dis; 2014 Oct; 15(10):525-37. PubMed ID: 25060294
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of (18)F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer.
    Altini C, Niccoli Asabella A, De Luca R, Fanelli M, Caliandro C, Quartuccio N, Rubini D, Cistaro A, Montemurro S, Rubini G.
    Abdom Imaging; 2015 Jun; 40(5):1190-202. PubMed ID: 25348731
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer.
    Lambrecht M, Deroose C, Roels S, Vandecaveye V, Penninckx F, Sagaert X, van Cutsem E, de Keyzer F, Haustermans K.
    Acta Oncol; 2010 Oct; 49(7):956-63. PubMed ID: 20586658
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
    Xu X, Sun ZY, Wu HW, Zhang CP, Hu B, Rong L, Chen HY, Xie HY, Wang YM, Lin HP, Bai YR, Ye Q, Ma XM.
    Radiat Oncol; 2021 Jul 19; 16(1):132. PubMed ID: 34281566
    [Abstract] [Full Text] [Related]

  • 8. Comparison of restaging accuracy of repeat FDG-PET/CT with pelvic MRI after preoperative chemoradiation in patients with rectal cancer.
    Huh JW, Kwon SY, Lee JH, Kim HR.
    J Cancer Res Clin Oncol; 2015 Feb 19; 141(2):353-9. PubMed ID: 25181962
    [Abstract] [Full Text] [Related]

  • 9. 18F-FDG-PET evaluation of treatment response to neo-adjuvant therapy in patients with locally advanced rectal cancer: a meta-analysis.
    Zhang C, Tong J, Sun X, Liu J, Wang Y, Huang G.
    Int J Cancer; 2012 Dec 01; 131(11):2604-11. PubMed ID: 22447461
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.
    Song I, Kim SH, Lee SJ, Choi JY, Kim MJ, Rhim H.
    Br J Radiol; 2012 May 01; 85(1013):577-86. PubMed ID: 21343320
    [Abstract] [Full Text] [Related]

  • 12. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
    Schouten CS, de Graaf P, Alberts FM, Hoekstra OS, Comans EF, Bloemena E, Witte BI, Sanchez E, Leemans CR, Castelijns JA, de Bree R.
    Oral Oncol; 2015 May 01; 51(5):541-7. PubMed ID: 25725587
    [Abstract] [Full Text] [Related]

  • 13. Combined use of 18F-FDG PET/CT, DW-MRI, and DCE-MRI in treatment response for preoperative chemoradiation therapy in locally invasive rectal cancers.
    Gu J, Khong PL, Wang S, Law W, Chan T, Shek TW, Liu R, Zhang J.
    Clin Nucl Med; 2013 May 01; 38(5):e226-9. PubMed ID: 23235482
    [Abstract] [Full Text] [Related]

  • 14. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
    Giganti F, De Cobelli F, Canevari C, Orsenigo E, Gallivanone F, Esposito A, Castiglioni I, Ambrosi A, Albarello L, Mazza E, Gianolli L, Staudacher C, Del Maschio A.
    J Magn Reson Imaging; 2014 Nov 01; 40(5):1147-57. PubMed ID: 24214734
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
    Tsuji K, Kishi S, Tsuchida T, Yamauchi T, Ikegaya S, Urasaki Y, Fujiwara Y, Ueda T, Okazawa H, Kimura H.
    J Magn Reson Imaging; 2015 Jun 01; 41(6):1601-7. PubMed ID: 25111444
    [Abstract] [Full Text] [Related]

  • 19. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T, Tatsumi M, Onishi H, Nakamoto A, Kim T, Hori M, Sakane M, Hori Y, Morii E, Hatazawa J, Tomiyama N.
    Invest Radiol; 2014 Aug 01; 49(8):524-31. PubMed ID: 24637584
    [Abstract] [Full Text] [Related]

  • 20. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW, Min JJ, Lee JH, Kim HR, Kim YJ.
    Am J Clin Oncol; 2012 Aug 01; 35(4):340-4. PubMed ID: 21422901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.